. . At the request of a few posters who want to start afresh, welcome to the IXC charting thread going forward!If you're a poster who is inclined to track TA,. Created with Sketch. Market Wrap - Top 3 Gainers #ASXGainers: $IXC 54. , page-2. 20. Very tempted to buy them back today at 19c. Join the HotCopper ASX share market forum today for free. Latest Posts. . ASX - Day TradingQuarterly Activities/Appendix 4C Cash Flow ReportMarch 20 (Reuters) - Invex Therapeutics Ltd (IXC) : APPROVAL TO COMMENCE IIH EVOLVE PHASE III CLINICAL TRIAL RECEIVED FROM BUNDESINSTITUT FÜR. Advertise on HotCopper. ASX - General. . See page-34. 79 -0. ASX - By Stock. 0. . ASX - General. ASX - By Stock. Join the HotCopper ASX share market forum today for free. IXC Price at posting: 79. Last edited by ejjwj: 28/06/23. , page-136. 0¢ Sentiment: Buy Disclosure: HeldHotCopper has news, discussion, prices and market data on GENESIS MINERALS LIMITED. , page-5. Market . I think IXC has the potential to do better. IXC current EV is close to $0 so again Im not sure what OSL valuation is but I dont think it stacks up as good as IXC and where IXC is at in its timeline. Market Cap $102. . AX stock on Yahoo Finance. ASX - General. Last updated 10. Latest Posts. . Created with Sketch. Access the latest research articles and market investment insight for INVEX THERAPEUTICS LTD seamlessly. gov and there is lots of good information about the trial. IXC Valuation Report MST. Forums. Anyone had a look at this or put an application in for some stock in the IPO?Created with Sketch. sentiment based on opinions from HotCopper and others. 10 Upvote. RDN Raiden Resources secures complete control of lithium at Arrow Project, buys out Arrow Minerals Ltd. Update - Notification regarding unquoted securities - IXC. Sentiment for Invex Therapeutics Ltd. Last research or update on this I listened to was by FiftyOneCapital. Latest Posts ForumsiShares Global Energy ETF (IXC) Add to watchlist NYSEArca - Nasdaq Real Time Price. Target our investor community with our suite of Hotcopper Advertising. My. ASX - Day TradingI bought some today at 44. Share Appreciate the commentary and post. You’d be surprised the volume that comes in when this happenes, but by that stage you’ll be 100% up whilst the opportunity cost traders will be trying to catch the move up. , page-17. Just a matter of time really. ASX - By Stock. Chairman's Address to Shareholders and PresentationHi guys, after discussion with Tom I have kind of mapped out the timeline to what is to be achieved. That is fair and as I mentioned in my initial post when buying, the business is worth the cash in ST. . Last updated 15. Created with Sketch. Both approaches can work, but it is not wise to confuse the two. Interexchange Carrier, also known as IXC, is a telco that mainly provides long-distance communication services. Hopefully they hit the miracle, at least I get something back from this if it goes balls up which in the bio world at the moment is highly likely. 0¢ Sentiment: Buy Disclosure: Held Bumping up this thread as $3. I bought the chart from base lows looking for a trade. 0¢ Sentiment: Buy Disclosure: Held. Forex. ASX - General. 5¢ Sentiment: Buy Disclosure: Held Created with Sketch. So it seems that as of 18 July the trials are still recruiting! An update was submitted to this site 3 days. Login to your CommSec account to buy. ASX - Short Term Trading. Market Cap $16. Im not expecting anything out of the ordinary apart from the fact thats its overdone and too undervalued at the stage its at. STN Saturn Metals reports high-grade gold intersections and visible gold at Apollo Hill, WAInvex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. 10 cents a week and we will be at $2 plus in no time. Invex Receives Approval for Paediatric Plan from the EMA, page-2. Latest Posts. The fact it recovered and closed about the 1. Created with Sketch. @FullMoonFever Another chart request if you are up for it please thanks in advance, page-7. Created with Sketch. Appreciate your input Dr T. Last updated 15. boolish Jellyroll hey. 30 Haven’t supported share price since then on market . ASX - By Stock. Created with Sketch. , page-2. , page-5. . . , page-20. , page-5. Currency in USD 38. Both approaches can work, but it is not wise to confuse the two. ASX - By Stock. ASX - By Stock. . @FullMoonFever Another chart request if you are up for it please thanks in advance, page-3. Created with Sketch. At the request of a few posters who want to start afresh, welcome to the IXC charting thread going forward!If you're a poster who is inclined to track TA,. Market . Posted without a title, my bad hahaI was going for something like Invex - How much is it worth, when Phase 2 results hit in March 2020?Got this from IXC by email today. Created with Sketch. Probably been disappointed like all of usCreated with Sketch. ASX - By Stock. , page-2. AdINVEX THERAPEUTICS LTD (ASX:IXC) - IXC chart, page-1 - HotCopper | ASX Share Prices, Stock Market & Share Trading Forum Forums ASX - By Stock IXC. 0. ASX - General. ASX - By Stock. IXC. Given the quality of the posters on the IXC thread I am confident others will do the same. Im not expecting anything out of the ordinary apart from the fact thats its overdone and too undervalued at the stage its at. ASX - Day TradingApril 20 (Reuters) - Invex Therapeutics Ltd (IXC) : MINISTRY OF HEALTH APPROVAL FOR IIH EVOLVE CLINICAL TRIAL IN ISRAELInvestor Presentation, page-2. Andrew Forrest , or his entities have been involved with IXC since inception. Created with Sketch. , page-2. Advertise on HotCopper. 0¢ Sentiment: Buy Disclosure: Held. View daily, weekly or monthly formats back to when Invex Therapeutics Ltd stock was issued. Investor PresentationInvex Successfully Concludes Protocol Assistance with EMACreated with Sketch. 50%. Charts. ASX - By Stock. ASX - Day TradingCreated with Sketch. 2 years ago biotech stocks were in vogue and hence NEU was fairly priced at $1. 0 Great. 5¢ Sentiment: Buy Disclosure: Held. Webinvest Pty Ltd<Olsb Unit A/C>. Advertise. Trading HaltIXC Valuation Report MST. ASX - General. 1. I'm topping up. With regard to costs, I'm encouraged by this statement in the release: Overall, the changes are expected to be cash neutral with respect to the original IIH EVOLVE trial costing, with recruitment anticipated to materially accelerate due to an expected significant reduction in pre-screen and screen failures. Release Date: 20/03/23 08:11; Summary: German Approval for IIH EVOLVE Phase 3 Clinical Trial; Price Sensitive: Yes; Download Document 195. com. Created with Sketch. ASX - General. Good fundamental research starting points for IXC:Summary: IXC FactsheetMST Analyst Equity Research ReportFiftyOne Capital ReportPresentation - Tom Duthy. Market open. , page-3. . Latest Posts. Share Would anyone know whether the 28c cash backing strips out all of the options listed in the notice? or is it included and they will fall away on strike dates?wonder if the GLP-1 agonist referred to in this media release. Forums. The IXC stock may trade low due to this wider macroeconomic issues, but the business itself is top 5% to its peers merely from the fact of having no future funding requirements and that if the trial is a success having close to immediate revenues and default alive status via Peptron manufacturing contract fulfilling demand on potential FDA. Forums. Created with Sketch. 38 was the valuation MST gave IXC 9 months ago Considering we are now even further de-risked, getting to the end result, wonder what MST valuation would be now. LATEST NEWS: Toubani Resources releases MRE update for Kobada gold project, Mali. Invex Therapeutics' Chief Scientific Officer, Professor Alexandra Sinclair, met with NASA's medical team. 1950. Trading HaltIXC Valuation Report MST. ASX - Short Term Trading. Share I've got no issues with it. Created with Sketch. 0% $ODM 35. Notification regarding unquoted securities - IXC Hi All, I have decided to make an IXC broker data thread, as my PAR broker data thread was very well received. 54pm 22/11/2023 ? HotCopper has news, discussion, prices and market data on INVEX THERAPEUTICS LTD. But lets not talk about NSB here, we are here to see progress with IXC. @FullMoonFever Another chart request if you are up for it please thanks in advance, page-5. This was roughly 50/50 between lost wages and direct medical costs. Loading. ASX - General. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. 0. Latest Posts. Created with Sketch. Company has options because they have cash. IAMIncome Asset Management to boost bond sales through partnership with Netwealth. Advertise on HotCopper. ASX. . Forums. My understanding is that NEU went from around $1. Probably been disappointed like all of us Created with Sketch. Market . ASX - Day TradingTo name a few other biotechs that have gotten belted by the market of the last few months that have had decent bounces such as NOX, NYR and PEB. . Target our investor community with our suite of Hotcopper Advertising opportunities. Given that IXC's Chief Scientific Officer, Alex Sinclair, is the author of IIH treatment guidelines, the introduction of an effective medication to the market would likely lead to a rapid integration of Presendin into treatment protocols. Join HotCopper today. Appendix 4E and Annual Report, page-2. 5¢ Sentiment: Hold Disclosure: Held IXC Valuation Report MST. More. I guess that&amp;apos;s why retail performs so poorly on average, so many think they are long term investors but can&amp;apos;t hold onto their shares for more. ASX - Short Term Trading. 1950. @FullMoonFever Another chart request if you are up for it please thanks in advance, page-4. Friday we moved 55% off 690k volume. ASX - By Stock. Created with Sketch. Created with Sketch. Created with Sketch. 8M ! Add to my watchlist. Created with Sketch. Lucky for you all IXC still sits at only 60 cents. Cannot wait. ASX - By Stock. " Seems a bit rough, anyone would think they are trying to minimise the number of SH who 'attend' the AGM. ASX - Day TradingCreated with Sketch. . ASX - By Stock. Market . 64440. US data averaged $2314 per person in direct medical care, the total average direct cost per IIH admission was 4x that or $9256. Hi Hot Copper, this will be a master thread for my daily posting of the Pharma Market Watchlist, please only keep commentary to the watchlist. , page-4. Created with Sketch. Created with Sketch. British Columbia, Selkirk Mountains. More progress made towards the start of Phase III, we have now made it on to the clinicltrials. Share Not unexpected. ASX - By Stock. Australian finance news, stock quotes, currency information and blogs Active Funds. Invex Granted Key European Patent for Exenatide, page-2. . Created with Sketch. Cold Comfort Ice Cream Company, Victoria, British Columbia. 54am 24/11/2023 ? HotCopper has news, discussion, prices and market data on INCA MINERALS LIMITED. Interexchange carriers (IXCs) own or share the various high-bandwidth, fiber-optic trunk lines that cross the country and provide high-speed switched digital services for voice, data, and video communication. ASX - By Stock. Plans & Pricing. . 31% more bullish than other Healthcare sector stocks. ASX - Day TradingWith debt too expensive and lots of very discounted capital raisings especially in the microcap part of the market, I'd like to think that IXC can take advantage of the fact that they have cash. Not sure what software this is but is there a way you can send the document itself, is a tad tough to read it with the photo you sent, if not all good, page-4. . 30 to $15 in the space of 1 and half years Bios move fast when value is recognised. Created with Sketch. Report to HotCopper and itll be the end of it, cheers. Below is the broker data for IXC November to. 54am 24/11/2023 ? HotCopper has news, discussion, prices and market data on INCA MINERALS LIMITED. Market . ASX - By Stock. If nothing has occurred with IXC for 2-3 days, we are happy to see no posts for 2-3 days, when there is excitement around a new development, then we can all get together to discuss and speculate. IXC Price at posting:. ASX - By Stock. Transparency is our policy. IXC has not had a decent bounce at all as yet, maybe still some sellers lurking. Jellyroll, arkangel, CD, balkanbroker to name a few have laid out some pretty compelling thesis' on where IXC will be heading. Timeline Annotations of the IXC Chart Story Thus Far - IXC IPO'd in mid 2019 with Phase II data due Mid 2020, stock performs very well on IPO with tight T20 - The stock rose in anticipation for the Mid 2020 Phase II data read out in early 2020 - Before crashing alongside the Covid 19 Market Crash Hysteria in March 2020 AND all volume the last 18 months has led to a higher T20 ownership) meanwhile we have a mere 3 posts regarding an IXC job listing for a CMO that's description can be interpreted as hinting at a second indication. ASX - By Stock. Invex Granted Type C Meeting with FDA, page-3. Backed by Twiggy. Join the HotCopper ASX share market forum today for free. 31% more bullish than other Healthcare sector stocks. Results of MeetingFor those curious about the T20 moves over the last 2 months of available data;Underlined = UnchangedGreen = Positive ChangeRed = Negative ChangeDYOR, not. They'll still have 14-15M in cash plus ODD for TBI in Europe and soon, one from the FDA, with plans for a P2 TBI study. IXC is at base, so it’s just a matter of when it’ll leave base and start turning to the upside. Trading HaltDCF Valuation: IXC Intrinsic Value of $6. 76 (-1. , page-6. A new thread to put trading comments / reasoning / opinions in. You are the controller for IXC, you call the shots to make the company as best as possible for shareholders - this means retaining talent and forwarding the company to Phase III success and beyond. I don't mind a capital return but you have to think that a reverse take over of some sort can happen here and that IXC would have lots of choices. But there are two key factors that make me hope that the BoD pursues the Phase 2, but I worry that JP and co will push for the. I'm thinking of flying there myself!Prof Alex Sinclair is to present in Melbourne and Sydney next. 5¢ Sentiment: Buy Disclosure: HeldAt the request of a few posters who want to start afresh, welcome to the IXC charting thread going forward!If you're a poster who is inclined to track TA,. . All the latest Invex Therapeutics Ltd (ASX:IXC) share price movements, news, expert commentary and investing advice from The Motley Fool Australia. ASX - Day Trading. . ASX - Day TradingSomeone bought $500 stock today at 44 cents. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. , page-3. Created with Sketch. Below is the broker data for IXC November to. . Maybe more common that what people think, imagine once GPs start diagnosing it even better if a treatment is developed, Prevalence could increase 2 or times which ultimately increases. 6million shares?, and if so is anyone worried about this, release date 29th. ASX - By Stock. Notification of cessation of securities - IXC. , page-32. 59). ASX - By Stock. Invex Therapeutics Ltd. Created with Sketch. ASX - Short Term Trading. Latest Posts. You are the controller for IXC, you call the shots to make the company as best as possible for shareholders - this means retaining talent and forwarding the company to Phase III success and beyond. We are a team of expert financial advisers each specialising in different, yet complementary areas. 50%. IXC on the other hand with nearer catalysts has already done its basing cycle Of course different stock different TAMS etc etc, probably why IMU is worth 640 mill MC and IXC 28 mill MC But again its why IXC is offering so much more in terms of value atm plus risk v reward All IMO of course, but yeh maybe some IMU investors pop across. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. ASX - By Stock. Good fundamental research starting points for IXC:Summary: IXC FactsheetMST Analyst Equity Research ReportFiftyOne Capital ReportPresentation - Tom Duthy. ASX - Day TradingAlthough with IXC fully cashed up it makes this fall irrational and the odd one out of alot of these small cap speccies that are death spiralling - aka, opportunity . 26 area could be wrong and it could go for example to $3. At that time the total costs of IIH exceeded $444,000,000. Information. Notice of Quarterly Investor Call. . Liked by Jackie Cox-Ziegler, CPHR. 6 Upvote. . Management have earmarked this a significant milestone - given they previously tied it to performance. Created with Sketch. Last edited by jellyroll: 27/02/23. *Close price adjusted for splits. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical developmentNotice of Annual General Meeting/Proxy Form. 05. All the latest Invex Therapeutics Ltd (ASX:IXC) share price movements, news, expert commentary and investing advice from The Motley Fool. ASX - Short Term Trading. ASX - Short Term Trading. Created with Sketch. . . **Close price adjusted for splits and dividend and/or capital gain distributions. IXC Valuation Report MST. All IMO IXC Price at posting: 37. View daily, weekly or monthly formats back to when Invex Therapeutics Ltd stock was issued. Australia's largest stock trading and investment forum Australia's #1 stock forumMay 18 (Reuters) - Invex Therapeutics Ltd (IXC) : INVEX THERAPEUTICS SEEKS TRADING HALT PENDING RELEASE ON RESULTS OF ITS PHASE II TRIAL & UNDERTAKING A. ASX - Day Trading. ASX - By Stock. Charts. Appendix 4E and Annual Report, page-3. Exciting times now that IXC is finally on the map!!! FYI considering charting is subjective that 1. Of course, IXC’s BoD need to win back credibility for the market to more fairly value IXC’s TBI ODD… Having gone through the roller-coaster over the past one week, with my emotions now settled – I will be (slowly) buying-up in. The Calmer Co (ASX:CCO) breaks new ground in Australian Retail with Kava shots to launch in Coles from January 2024Hi guys, after discussion with Tom I have kind of mapped out the timeline to what is to be achieved. . Charts. Yet since market announcement of Phase 2 completion, this. Spot on - filled the 1. is there any news release, or SP increasing due to only the market showing interestInvex Receives UK Approval to Commence Phase III TrialInvex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. Market . Global Phase 3 Trial of Presendin to Launch in Q4 2021Invex receives IND approvalInvex Receives Written Response from FDA on Type C Meeting, page-2. , page-3. Exciting times now that IXC is finally on the map!!! FYI considering charting is subjective that 1. Join the HotCopper ASX share market forum today for free. . Invex Granted Type C Meeting with FDAAppendix 4E and Annual Report to shareholders. , page-5. 26 area could be wrong and it could go for example to $3. International Markets. Commodities. ASX - Day Trading. Latest Posts ForumsHalf Yearly Report and AccountsLooks like people are starting to wake up here and realise how bloody cheap IXC is. Created with Sketch. ASX - Day TradingChange in substantial holding. International Markets. Latest Posts. Hi guys, after discussion with Tom I have kind of mapped out the timeline to what is to be achieved. IXC (ASX) Ann: Trading Halt - HotCopper. 0¢ Sentiment: Buy Disclosure: Held Created with Sketch. . Latest Posts. . 79 -0.